First Header Logo Second Header Logo

Connection

Samuel Lentz to Estrogen Antagonists

Back to Details
This is a "connection" page, showing publications Samuel Lentz has written about Estrogen Antagonists.
Samuel Lentz
Connection Strength
0.058
Estrogen Antagonists
  1. Covens A, Brunetto VL, Markman M, Orr JW, Lentz SS, Benda J. Phase II trial of danazol in advanced, recurrent, or persistent endometrial cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2003 Jun; 89(3):470-4.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.